期刊文献+

肺泡表面活性物质联合鼻塞持续气道正压通气治疗早产儿呼吸窘迫综合征的疗效及护理 被引量:11

Effect and nursing of pulmonary surfactant combined continuous positive airway pressure therapy premature infants with respiratory distress syndrome
下载PDF
导出
摘要 目的:观察肺泡表面活性物质治疗早产儿呼吸窘迫综合征的疗效。方法:将156例呼吸窘迫综合征患儿随机分为治疗组(78例)及对照组(78例)。治疗组于出生后30min~2h从气管插管内滴入肺泡表面活性物质(固尔苏),每次100~200mg/kg,用药后应用鼻塞持续气道正压(NCPAP)装置辅助呼吸;对照组单纯应用NCPAP装置辅助呼吸。两组其他治疗及护理措施相同。结果:治疗组辅助呼吸、机械通气、住院时间明显缩短,与对照组比较,差异有显著性(均P<0.05);治疗组72h胸部X线摄片正常率高于对照组(P<0.05)。结论:保持呼吸道通畅,采取正确的氧疗和加强机械通气的管理,配合早期足量的应用肺泡表面活性物质,可提高呼吸窘迫综合征患儿的疗效和缩短病程。 Objective :To observe the effect of pulmonary surfactant treatment of respiratory distress syndrome in premature infants. Methods :156 eases of respiratory distress syndrome in premature infants were randomly divided into treatment group (78 cases) and control group (78 cases). Treatment group was born from 30 rain to 2 h instillation with endotracheal intubation pulmonary suffactant (Curosuff) 100 -200 mg/kg. Pertime, after drug application of nasal continuous positive airway pressure (NCPAP) ventilation devices;control simple application of NCPAP group assisted breathing device; the others with the same treatment and care measures in two groups. Results:The treatment group - assisted breathing, Mechanical ventilation, length of stay was significantly shorter, compared with the control group, there were significant differences (all P 〈 0.05 ) ;72 h chest X -ray rate in treatment group was higher than in control group (P 〈 0.05 ). Conclusion :Maintain airway, oxygen therapy and the fight to take to strengthen the management of mechanical ventilation, with early application of adequate pulmonary surfactant, to improve prevention and treatment of complications in premature infants with respiratory distress syndrome in children with the efficacy and shorten the course.
作者 张秀娥
出处 《护理实践与研究》 2010年第5期37-39,共3页 Nursing Practice and Research
关键词 肺泡表面活性物质 持续气道正压通气 早产儿 呼吸窘迫综合征 Pulmonary suffactant Continuous positive airway pressure Premature infants Respiratory distress syndrome
  • 相关文献

参考文献3

二级参考文献22

  • 1[3]Otis DR, Johnson M, Pedley TJ, et al. Role of pulmonary surfactant in airway closure : A computational study. J Appl Physiol, 1993, 75(3): 1323- 1333.
  • 2[4]Hohlfeld J, Tiryaki E, Hamn H, et al. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Med, 1998, 158(3): 706- 712.
  • 3[5]McCormack FX, Whitsett JA. The pulmonary collectins, SP-A and SP-D, or chestrate innate immunity in the lung. J Clin Invest, 2002, 109(6): 707- 712.
  • 4[6]Kremlev SG, Umstead TM, Phelp DS. Surfactant protein A egulates cytokine production in the monocytic cell line THP-1. Am J Physiol, 1997, 272( 5pt 1): L996 - 1004.
  • 5[7]Augusto LA, Li J, Synguelakis M, et al. Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J Biol Chem, 2002, 277(26): 23484- 23492.
  • 6[8]Harrod KS, Trapnell BC, Otaka K, et al. SP-A enhances viral clearance and inhibits inflammation after pulmonary adenoviral infection. Am J Physiol, 1999, 277(3pt1): L580- 588.
  • 7[12]Hentschel R, Jorch GJ. Acute side effects of surfactant treatment. Perinat Med, 2002, 30(2): 143- 148.
  • 8[13]Walmrath D, Grimminger F, Pappert D, et al. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: Impact on gas exchange and haemodynamics. Eur Respir J, 2002, 19(5): 805- 810.
  • 9Lal L,Kotecha S.Surfactant therapy.Journal of Neonatal Nursing.2000,2(6):Step by step geide.
  • 10Wallace JL.Suctioning - a two-edged sword:Reducing the theory - practice gap.Journal of Neonatal Nursing.1998,6(4):12-17.

共引文献100

同被引文献76

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部